Stent grafting in the superficial femoral artery

被引:0
作者
Vykoukal, D. [1 ]
Davies, M. G. [1 ]
机构
[1] Methodist Hosp, Dept Cardiovasc Surg, Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA
来源
ITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY | 2010年 / 17卷 / 01期
关键词
Femoral artery; Stents; Angioplasty; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; MUSCLE CELL-PROLIFERATION; EXPANDING NITINOL STENTS; RAT CAROTID-ARTERY; LONG-TERM SUCCESS; BALLOON ANGIOPLASTY; OCCLUSIVE DISEASE; FEMOROPOPLITEAL ARTERIES; NEOINTIMAL HYPERPLASIA; INTIMAL HYPERPLASIA;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angioplasty and stents fail due to the development of intimal hyperplasia and material failures. The development of covered stents has been based on the creation of a barrier to intimal hyperplasia ingrowth by provision of a barrier to lumina! ingrowth. Angioplasty is a controlled injury to the vessel wall. The injury leads to a healing response in the intima and media, which involves a program of cell apoptosis, cell migration, cell proliferation and extracellular matrix deposition. The intimal hyperplasic process in a stent is more prolonged and robust than in a balloon-injured artery and is proportional to the depth of injury that the recipient vessel sustains and the inflammatory response induced. The development of covered stents has been based on the creation of a barrier to intimal hyperplasia ingrowth by provision of a barrier to luminal ingrowth The "ideal indications" for stent grafting have been reported to be segments with a length of >= 1 cm proximal and distal without any obstruction, no lesions in the popliteal artery, at least one open tibial vessel and no severe calcifications. In patients with "optimal" conditions for implantation (no heavy calcifications, popliteal obstruction, or complete superficial femoral artery occlusion; minimum 1-vessel runoff; and adequate antiplatelet therapy or anticoagulation), the primary/secondary patency rates have been found to be 80/91% after the first year, 71/89% after 3 years, and 62/90% after 5 years.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 90 条
[31]  
Ferrer P., 1996, FASEB Journal, V10, pA618
[32]  
Fischer M, 2003, ZBL CHIR, V128, P740
[33]   Value of the Hemobahn/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience [J].
Fischer, Matthias ;
Schwabe, Claudia ;
Schulte, Karl-Ludwig .
JOURNAL OF ENDOVASCULAR THERAPY, 2006, 13 (03) :281-290
[34]   TIME-COURSE OF FLOW-INDUCED SMOOTH-MUSCLE CELL-PROLIFERATION AND INTIMAL THICKENING IN ENDOTHELIALIZED BABOON VASCULAR GRAFTS [J].
GEARY, RL ;
KOHLER, TR ;
VERGEL, S ;
KIRKMAN, TR ;
CLOWES, AW .
CIRCULATION RESEARCH, 1994, 74 (01) :14-23
[35]  
GUIDOIN R, 1993, BIOMATERIALS, V14, P678, DOI 10.1016/0142-9612(93)90067-C
[36]   TIME COURSE OF SMOOTH-MUSCLE CELL-PROLIFERATION IN THE INTIMA AND MEDIA OF ARTERIES FOLLOWING EXPERIMENTAL ANGIOPLASTY [J].
HANKE, H ;
STROHSCHNEIDER, T ;
OBERHOFF, M ;
BETZ, E ;
KARSCH, KR .
CIRCULATION RESEARCH, 1990, 67 (03) :651-659
[37]   Efficacy of Hemobahn® in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia:: A comparative study with claudicants [J].
Hartung, O ;
Otero, A ;
Dubuc, M ;
Boufi, M ;
Barthelemy, P ;
Aissi, K ;
Alimi, YS .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2005, 30 (03) :300-306
[38]   Occlusive and aneurysmal peripheral arterial disease: Assessment of a stent-graft system [J].
Henry, M ;
Amor, M ;
Cragg, A ;
Porte, JM ;
Henry, I ;
Amicabile, C ;
Tricoche, O .
RADIOLOGY, 1996, 201 (03) :717-724
[39]   Patterns and mechanisms of in-stent restenosis - A serial intravascular ultrasound study [J].
Hoffmann, R ;
Mintz, GS ;
Dussaillant, GR ;
Popma, JJ ;
Pichard, AD ;
Satler, LF ;
Kent, KM ;
Griffin, J ;
Leon, MB .
CIRCULATION, 1996, 94 (06) :1247-1254
[40]  
HUNINK MGM, 1993, J VASC SURG, V17, P183